Home Others Others Enoxaparin sodium

research use only

Enoxaparin sodium

Cat.No.S5415

Enoxaparin sodium(PK 10169) is a low-molecular-weight heparin used to prevent and treat deep vein thrombosis or pulmonary embolism. It binds to and accelerates the activity of antithrombin III.
Enoxaparin sodium Chemical Structure

Chemical Structure

Jump to

Quality Control

Batch: S541501 Water]100 mg/mL]false]DMSO]Insoluble]false]Ethanol]Insoluble]false Purity: 98%
98

Solubility

In vitro
Batch:

Water : 100 mg/mL

DMSO : Insoluble
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight Formula Storage (From the date of receipt) 3 years -20°C powder
CAS No. 679809-58-6 -- Storage of Stock Solutions

Synonyms PK 10169 SMILES CC1C(C(OC(C1OC2CC(C(C(C2O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C=C(O4)C(=O)[O-])O)O)O)NC(=O)C)C(=O)[O-])CO)OC5C(C(C(OC5C(=O)[O-])OC6C7COC(O7)C(C6O)NS(=O)(=O)[O-])O)O)NC(=O)C.[Na+].[Na+].[Na+].[Na+]

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-05-26)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06628778 NOT_YET_RECRUITING
Venous Thromboembolism (VTE)
Johns Hopkins All Children's Hospital
 2027-04-15 PHASE3
NCT07796737 NOT_YET_RECRUITING
Pregnancy Loss; Pregnancy Loss, Early
General University Hospital, Prague
 2026-12-01 PHASE3
NCT07499037 NOT_YET_RECRUITING
Pneumonia; Heart Failure
University Hospital Ostrava
 2027-01 PHASE2
NCT06370273 RECRUITING
Thrombosis; Injury Leg
Queen Mary University of London
 2024-11-12 PHASE3
NCT07506473 NOT_YET_RECRUITING
Severe Trauma Patient; Venous Thromboembolism
University Hospital, Grenoble
 2026-04
NCT03244020 ENROLLING_BY_INVITATION
Sarcoma; Soft Tissue Sarcoma; Bone Sarcoma; Bone Metastases; Venous Thromboembolism; Hematoma; Anticoagulant-induced Bleeding
Massachusetts General Hospital
 2018-02-16 PHASE4

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.